Conditions: Chronic Motor or Vocal Tic Disorder Tourette's Disorder
Keywords: Chronic Motor Tic disorder Chronic Phonic Tic disorder Tourette's disorder Aripiprazole Abilify Children Adolescent
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 61
Healthy volunteers: no

Brief summary:
The purpose of this trial is to demonstrate the efficacy and safety of aripiprazole in children and adolescents aged 6\~18 years with chronic tic disorders or Tourette's disorder

Detailed description:

Arms:
arm 1: Aripiprazole 2mg,5mg,10mg,15mg,20mg orally administrated Once a day (Titration according to the protocol) arm 2: Placebo 2mg,5mg,10mg,15mg,20mg orally administrated Once a day (Titration according to the protocol)

Interventions: intervention 1: aripiprazole intervention 2: placebo
Intervention descriptions: intervention 1: Initial dose : 2mg, Maximum dose : 20mg intervention 2: Initial dose: 2mg, Maximum dose:20mg

Protocol document: